권익찬 (한국과학기술연구원(KIST))님 | 한빛사연구자 > 한빛사

한국과학기술연구원(KIST)

CV File

바이오·의료융합 기타

최종업데이트 2024.04.19.

Targeting and exploiting macropinocytosis in cancer therapy
- J. Control. Release, Jun 16 2025, S0168-3659(25)00582-6 | https://doi.org/10.1016/j.jconrel.2025.113962
- 2025-06
- 바이오·의료융합
- 한빛사논문
Receptor-ligand interactions for optimized endocytosis in targeted therapies
- J. Control. Release, Jan 26 2025, S0168-3659(25)00070-7 | https://doi.org/10.1016/j.jconrel.2025.01.060
- 2025-01
- 바이오·의료융합
- 한빛사논문
Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade
- Adv. Drug Deliv. Rev., Available online 16 April 2024, 115306 | https://doi.org/10.1016/j.addr.2024.115306
- 2024-04
- 바이오·의료융합
- 한빛사논문
Alliance with EPR effect: combined strategies to improve the EPR effect in the tumor microenvironment
- Theranostics, 2019, 9 (26) | https://doi.org/10.7150/thno.37198
- 2019-09
- 바이오·의료융합
- 상위피인용논문
Controlled spatial characteristics of ligands on nanoparticles: Determinant of cellular functions
- J. Control. Release, Vol 360, Aug 2023, Pages 672-686 | https://doi.org/10.1016/j.jconrel.2023.07.020
- 2023-08
- 바이오·의료융합
- 한빛사논문
Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy
- J. Control. Release, Volume 351, November 2022, Pages 713-726 | https://doi.org/10.1016/j.jconrel.2022.09.040
- 2022-11
- 바이오·의료융합
- 한빛사논문
Ultraefficient extracellular vesicle–guided direct reprogramming of fibroblasts into functional cardiomyocytes
- Sci. Adv., 25 Feb 2022 • Vol 8, Issue 8 |10.1126/sciadv.abj6621
- 2022-02
- 바이오·의료융합
- 한빛사논문
A Trojan-Horse Strategy by In Situ Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA
- ACS Nano, Publication Date:June 30, 2021 | https://doi.org/10.1021/acsnano.1c00799
- 2021-06
- 바이오·의료융합
- 한빛사논문
Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice
- J. Control. Release, Volume 144, Issue 2, 1 June 2010, Pages 134-143 | https://doi.org/10.1016/j.jconrel.2010.02.023
- 2010-06
- 바이오·의료융합
- 상위피인용논문
Tumor‐Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity
- Adv. Mater., First published: 09 October 2020 | https://doi.org/10.1002/adma.202002197
- 2020-10
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기